Simple and reliable HPLC analysis of fexofenadine hydrochloride in tablets and its application to dissolution studies

Pharmazie

Volumn 62, Issue 2, 2007, Pages 96-100

  Oliveira, D C ^a   Weich, A ^a   Rolim, C M B ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; FEXOFENADINE; METHANOL; TRIETHYLAMINE; TRIETHYLAMINE PHOSPHATE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; DISSOLUTION; DRUG FORMULATION; DRUG RELEASE; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

CALIBRATION; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HISTAMINE H1 ANTAGONISTS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SOLUBILITY; SPECTROPHOTOMETRY, ULTRAVIOLET; TABLETS; TERFENADINE;

EID: 33847101909     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2007.2.6120     Document Type: Article

References (16)

1. Bender BG, Berning S, Dudden R, Milgrom H, Tran ZV (2003) Sedation and performance impairment of diphenhydramine and second-generation antihistamines: A meta-analysis. J. Allergy Clin Immunol 111: 770-776.
2. Breier AR, Paim CS, Steppe M, Schapoval EES (2004) Development and validation of a liquid chromatographic method for fexofenadine hydrochloride in capsules. J AOAC Inter 87: 1093-1097.
3. Breier AR, Paim CS, Steppe M, Schapoval EES (2005) Development and validation of dissolution tests of fexofenadine hydrochloride capsules and coated tablets. J Pharm Sci 8: 289-298.
4. Chae KM, Tharp MD (2000) Use and safety of antihistamines in children. Dermatol Ther 13: 374-383.
5. Costa P; Lobo JMS (2001) Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13: 123-133.
6. 1-receptor antagonists in dosage forms. J Pharm Biomed Anal 30: 859-867.
7. ICH-Q2B, Guidance for Industry: ICH-Q2B (1997) Validation of Analytical Procedures: Methodology, Food and Drug Administration, Rockville, MD, 19 May.
8. Merck Index, an Encyclopedia of Chemicals, Dugs, and Biologicals. Merck & CO., INC. Whitehouse Station, NJ, 2001.
9. Moore JW; Flanner HH (1996) Mathematical comparison of curves with an emphasis on in vitro dissolution profiles. Pharm Technol 20: 64-74.
10. Pinto YM, Van Gelder IC, Heeringa M, Crijns HJGM (1999) QT legthening and life-threatening arrhythmias associated with fexofenadine.Lancet 353: 980.
11. Pratt CM, Mason J, Russell T, Reynolds R, Ahlbrandt R (1999) Cardiovascular safety of fexofenadine HCl. Am J Cardiol 83: 1451-1554.
12. Radhaknshna T, Reddy GO (2002) Simultaneous determination of fexofenadine and its related compounds by HPLC. J Pharm Biomed Anal 29: 681-690.
13. Rolim CMB, Junior LB, Fronza M, Malesuik MD, Bajerski L, Dalmora SL (2005) Development and validation of a method for the dissolution studies of bisoprolol in pharmaceutical dosage forms. Eur J Liq Chromat 28: 477-486.
14. 2. Dissolution Technol 6: 15.
15. 1 antihistamines: clinical relevance. Am J Med 113: 38-46.
16. th Ed., United States Pharmacopial Convention, Inc., Rockville, MD.